Market Tracker

10/31 4:05am ET

Impax Laboratories Inc (NASDAQ:IPXL)

28.62
Data as of Oct 30
 +0.43 / +1.53%
Today’s Change
19.67
Today|||52-Week Range
31.04
+13.84%
Year-to-Date

Today’s Trading

Previous close28.19
Today’s open28.04
Day’s range-- - --
Volume315,086
Average volume (3 months)611,922
Market cap$2.0B
Dividend yield--
Data as of 10/30/2014

Growth & Valuation

Earnings growth (last year)+79.27%
Earnings growth (this year)+42.02%
Earnings growth (next 5 years)+26.50%
Revenue growth (last year)-12.07%
P/E ratio1,431.0
Price/Sales3.29
Price/Book2.42

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+1.92+3.35%
IRWDIronwood Pharmaceuti...----
LCILannett Company Inc+3.40+6.48%
THRXTheravance Inc+0.47+2.99%
Data as of 10/30/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.31
Annual revenue (last year)$511.5M
Annual profit (last year)$101.3M
Net profit margin19.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior VP-Finance
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts